olanzapine
CHEBI:CHEBI_7735
Definition
A benzodiazepine that is 10H-thieno[2,3-b][1,5]benzodiazepine substituted by a methyl group at position 2 and a 4-methylpiperazin-1-yl group at position 4.
Chemical Information
- Molecular Formula
- C17H20N4S
- Molecular Mass
- 312.434
- Charge
- 0
- SMILES
- N1=C(C2=C(NC3=CC=CC=C13)SC(=C2)C)N4CCN(CC4)C
- InChI
- InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
- InChIKey
- KVWDHTXUZHCGIO-UHFFFAOYSA-N
Alternative Names
- 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
- olanzapina
- olanzapine
- Olanzapine
- olanzapinum
- Zyprexa
Drug Classification
-
benzodiazepineView Class →
CHEBI:22720
-
N-arylpiperazineView Class →
CHEBI:46848
-
N-methylpiperazineView Class →
CHEBI:46920
-
t292827
-
t292872
-
t293077
-
t293105
-
t293264
-
t293602
-
t293836
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 61381
- oboInOwl#hasDbXref
- Wikipedia:Olanzapine
- core#notation
- CHEBI:7735
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- product_ndc
- 63419-0509
- route
- INTRAMUSCULAR
- package_ndc
- 71335-0714-2
- spl_id
- c6e1cbe2-4d81-4b7c-b948-d64d9b3527a7
- listing_expiration_date
- 20251231
- package_description
- 100 kg in 1 DRUM (63419-0509-1)
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 61381
- oboInOwl#hasDbXref
- Wikipedia:Olanzapine
- oboInOwl#id
- CHEBI:7735
- generic_name
- Olanzapine pamoate monohydrate
- brand_name
- ZYPREXA Relprevv
- brand_name_base
- Symbyax
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_50919
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- marketing_start_date
- 19970623
- labeler_name
- RPK Pharmaceuticals, Inc.
- dosage_form
- INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- application_number
- ANDA210968
- nui
- N0000175430
- upc
- 0368071272062
- package_marketing_start_date
- 10-JAN-00
- rxcui
- 1718936
- manufacturer_name
- Dr. Reddy's Laboratories Ltd.
- unii
- 0AJQ5N56E0
- spl_set_id
- 4e90e30c-78a1-486f-a13c-f1ff798216be
- core#notation
- CHEBI:7735
- pharm_class
- Opioid Antagonists [MoA]
- pharm_class_epc
- Atypical Antipsychotic [EPC]
- brand_name_suffix
- Relprevv
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- active_ingredient_strength
- 405 mg/2.7mL
- active_ingredient_name
- OLANZAPINE PAMOATE
- has_treatment
- http://purl.obolibrary.org/obo/DOID_8689
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect34736
- owl#annotatedSource
- t293887
- owl#someValuesFrom
- t3811974